Evidence map›Paper›PMID 31051415›Full record

ArticleAtherosclerosis2019

Automated detection of superficial macrophages in atherosclerotic plaques using autofluorescence lifetime imaging.

Jose J Rico-Jimenez, Michael J Serafino, Sebina Shrestha, Xi Chen, Wihan Kim, Jessie Adame, L Maximillan Buja, Deborah Vela, Brian E Applegate, Javier A Jo

Open access · greenAbstract read
In one paragraph

Article in Atherosclerosis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jose J Rico-JimenezDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Michael J SerafinoDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Sebina ShresthaDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Xi ChenDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Wihan KimDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Jessie AdameAutopsy and Pathology Services, Houston, TX, USA.
L Maximillan BujaTexas Heart Institute, Houston, TX, USA.
Deborah VelaTexas Heart Institute, Houston, TX, USA.
Brian E ApplegateDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA.
Javier A JoDepartment of Biomedical Engineering, Texas A& M University, College Station, TX, USA; School of Electrical and Computer Engineering, University of Oklahoma, Norman, OK, USA. Electronic address: javierjo@ou.edu.
Texas A&M University · USTexas Dermatology and Laser Specialists · USUniversity of Oklahoma · US

Funding

Endogenous fluorescence lifetime endoscopy for early detection of oral cancer and dysplasiaR01CA218739 · NCI · UNIVERSITY OF OKLAHOMA · PI JO, JAVIER ANTONIO · 2018 to 2023
$2.5M
Morphological and Molecular Imaging System for in vivo Atherosclerosis ResearchR01HL111361 · NHLBI · TEXAS ENGINEERING EXPERIMENT STATION · PI APPLEGATE, BRIAN E. · 2012 to 2016
$1.7M
NCI NIH HHS R01 CA218739NHLBI NIH HHS R01 HL111361
6 · The paper itself

Abstract

BACKGROUND AND

aimsMacrophages play an important role in the development and destabilization of advanced atherosclerotic plaques. Hence, the clinical imaging of macrophage content in advanced plaques could potentially aid in identifying patients most at risk of future clinical events. The lifetime of the autofluorescence emission from atherosclerotic plaques has been correlated with lipids and macrophage accumulation in ex vivo human coronary arteries, suggesting the potential of intravascular endogenous fluorescence or autofluorescence lifetime imaging (FLIM) for macrophage imaging. The aim of this study was to quantify the accuracy of the coronary intima autofluorescence lifetime to detect superficial macrophage accumulation in atherosclerotic plaques.

methodsEndogenous FLIM imaging was performed on 80 fresh postmortem coronary segments from 23 subjects. The plaque autofluorescence lifetime at an emission spectral band of 494 ± 20.5 nm was used as a discriminatory feature to detect superficial macrophage accumulation in atherosclerotic plaques. Detection of superficial macrophage accumulation in the imaged coronary segments based on immunohistochemistry (CD68 staining) evaluation was taken as the gold standard. Receiver Operating Characteristic (ROC) curve analysis was applied to select an autofluorescence lifetime threshold value to detect superficial macrophages accumulation.

resultsA threshold of 6 ns in the plaque autofluorescence lifetime at the emission spectral band of 494 ± 20.5 nm was applied to detect plaque superficial macrophages accumulation, resulting in ∼91.5% accuracy.

conclusionsThis study demonstrates the capability of endogenous FLIM imaging to accurately identify superficial macrophages accumulation in human atherosclerotic plaques, a key biomarker of atherosclerotic plaque vulnerability.

Indexed as

MacrophagesOptical ImagingCadaverCoronary Artery DiseaseHumansPlaque, AtheroscleroticTime FactorsClassificationFluorescence lifetime imagingImage analysisMacrophage foam cellsMedical and biological imagingPlaque characterization

Identifiers

PMID31051415
PMCPMC6536321
OpenAlexW2938616354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.